For over 35 years, VASCUTEK has applied advanced and innovative technologies to develop a wide portfolio of products which include an extensive range of sealed woven and knitted polyester grafts for peripheral, abdominal and cardiothoracic surgery, ePTFE grafts and a custom AAA stent graft system.
VASCUTEK is a subsidiary of the Terumo Corporation of Japan, a premier global medical device company which was founded in 1921 and currently has over 21,000 employees worldwide.
In collaboration with our market representatives, clinicians from all over the world visit VASCUTEK's facilities near Glasgow and participate in our international workshops.
Research and Development
Collaboration between three highly respected groups to develop a new vascular graft.
VASCUTEK Ltd Founded
Development of our Gelatin Sealant
VASCUTEK's unique modified gelatin sealant:
*References available on request
1st Queen's Award for Enterprise
VASCUTEK is honoured to receive its first Queen's Award for Technological Achievements for the development of GelsealTM.
First Gelweave™ Grafts
Gelweave™ – a new design of zero porosity twill woven prosthesis.
First ePTFE Grafts
The current range includes:
VASCUTEK is proud to become part of Terumo Corporation
*Not approved for use in USA or Japan
ePTFE vascular prosthesis with flared outflow
Low friction hydrophilic coating significantly smoothes the passage of the delivery sheath through the arteries*
*References available upon request. Not available for use in USA and Japan.
Anaconda™ ONE-LOK Body
New ONE-LOK BODY* – additional ring stents designed to maximise lumen diameter and blood flow
*Not approved for use in USA and Japan
The world's first frozen elephant trunk device with aortic root plexus
Scottish Business Award for Innovation
VASCUTEK receives the company's second prestigious Business Innovation of the Year award this time for the development of Fenestrated Anaconda™
Anaconda™ – Expanded Indication
CE mark approval for Anaconda™ to be used to treat infrarenal abdominal aortic aneurysms in patients with proximal aortic neck angulations up to 90 degrees providing a clinical solution for patients with tortuous anatomy.
VASCUTEK Sewing Academy
The Sewing Academy provides a dedicated training facility for Associates to learn the skills required for sewing the many different components which form an integral part of a large number of products manufactured by Vascutek.
8th Queen’s Award for Enterprise
VASCUTEK is granted the highly prestigious Queen’s Award for Enterprise in the Innovation category for Thoraflex™ Hybrid
Scottish Enterprise Life Sciences Award
VASCUTEK receives the greatly respected Life Sciences Award for Export and International Trade.
2000th implant for ThoraflexTM Hybrid
To date, Thoraflex™ Hybrid has helped save the lives of almost 2,000 patients in 35 countries worldwide and is widely accepted as the gold standard of complex aortic treatment.*
*References available upon request
VASCUTEK adopts a zero tolerance approach to unethical behaviour. We operate in an environment involving both ethical and legal responsibilities that extend not just to our employees, but to our customers, healthcare professionals, and other organisations with which we do business. The directors, officers, employees, consultants, representatives and agents of VASCUTEK are required to behave in an ethical manner at all times, and to comply with all laws, regulations, policies and procedures that affect their positions.
Download the VASCUTEK Ethics Statement
Download the VASCUTEK Modern Slavery Act 2015 Statement
Download the Code of Conduct for the Terumo Group